A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a 2 week Phase 1 study of SB204 (NVN1000 Gel) in healthy adult volunteers with
elevated Propionibacterium acnes (P. acnes) counts. Subjects will apply NVN1000 4% Gel or
Vehicle Gel twice daily to their face. Assessments will include cutaneous tolerability,
safety, and P. acnes counts.